DEERFIELD, Illinois, Oct. 16 -- Baxter International, a health care company that focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions, issued the following news release:

* * *

Baxter to Host Third-Quarter 2025 Financial Results Conference Call

Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its third-quarter 2025 financial resul . . .

Click here for more information about our products